MITF and cell proliferation: the role of alternative splice forms

Related Experiment Video

Updated: Aug 15, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Keren Bismuth1, Dragan Maric, Heinz Arnheiter

  • 1Mammalian Development Section, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Pigment Cell Research
|September 16, 2005
PubMed

Insights

The microphthalmia-associated transcription factor (MITF) influences cell cycle regulation. Specific MITF isoforms, particularly (+) MITF, exhibit anti-proliferative effects independent of DNA binding.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The microphthalmia-associated transcription factor (MITF) regulates both differentiation and cell cycle genes.
  • MITF exists in splice isoforms with potentially distinct functions.
  • Two isoforms, (-) MITF and (+) MITF, differ in six residues near the DNA-binding domain.

Purpose of the Study:

  • To investigate the differential effects of MITF isoforms on DNA synthesis.
  • To determine the molecular mechanisms underlying the anti-proliferative activity of (+) MITF.

Main Methods:

  • In vitro BrdU incorporation assays.
  • FACS analysis in transiently transfected cells.
  • Site-directed mutagenesis to dissect MITF domains.

Main Results:

  • (+) MITF significantly inhibits DNA synthesis, while (-) MITF has minimal effect.
  • The anti-proliferative activity of (+) MITF is independent of its transcriptional activity and carboxyl terminus.
  • The amino terminus, particularly serine-73, is crucial for (+) MITF's inhibitory function.
  • Phosphorylation of serine-73 occurs similarly in both isoforms.

Conclusions:

  • Alternative splicing in MITF generates isoforms with distinct roles in cell proliferation.
  • (+) MITF possesses intrinsic anti-proliferative properties mediated by its amino terminus.
  • MITF's anti-proliferative function can operate independently of direct DNA binding to E boxes.

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...